While some data suggest that anemia is not an important prognostic factor, a large number of prospective and retrospective studies, as well as data from in vitro and in vivo studies, suggest that Hb levels may influence treatment outcome parameters (26–28). Here, GSTM1 is linked to anemia (phenotype).